Heartburn

·MeSH: Heartburn

15 drugs in development·7 companies·2 clinical trials

Drug Pipeline by Phase

Approved(15)

Drug	Company
dexlansoprazole	Mylan II B.V. (MYL)
esomeprazole magnesium	BRIGHT MINDS BIOSCIENCES INC. (DRUG)
esomeprazole magnesium	Mylan II B.V. (MYL)
esomeprazole magnesium	DR REDDYS LABORATORIES LTD (RDY)
esomeprazole magnesium	PERRIGO Co plc (PRGO)
esomeprazole magnesium	LANNETT CO INC (LCI)
esomeprazole magnesium	SUNSET ISLAND GROUP (SUN)
esomeprazole magnesium	EXELIXIS, INC. (EXEL)
famotidine	DR REDDYS LABORATORIES LTD (RDY)
lansoprazole	Mylan II B.V. (MYL)
omeprazole	DR REDDYS LABORATORIES LTD (RDY)
omeprazole	EXELIXIS, INC. (EXEL)
omeprazole magnesium	DR REDDYS LABORATORIES LTD (RDY)
omeprazole magnesium	EXELIXIS, INC. (EXEL)
omeprazole magnesium	PERRIGO Co plc (PRGO)

BioSniper tracks 15 drugs in development for Heartburn across 7 companies.

There are 2 clinical trials targeting Heartburn tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.